Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Lancet (London, England)|April 28, 2016
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trialRobert M Anthenelli, Neal L Benowitz, Robert West, et al.Journal of General Internal Medicine|March 9, 2019
Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES TrialRobert M Anthenelli, Michael Gaffney, Neal L Benowitz, et al.Journal of Addiction Medicine|July 20, 2011
Interrelated effects of substance use diagnosis, race, and smoking severity on abstinence initiation in dually dependent male smokers: results of a retrospective chart reviewJaimee L Heffner, Thomas J Blom, Elaine Camerota, et al.Addiction (Abingdon, England)|March 7, 2018
Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLESRobert West, A Eden Evins, Neal L Benowitz, et al.Journal of Studies on Alcohol and Drugs|March 21, 2017
Type A/Type B Alcoholism Predicts Differential Response to Topiramate in a Smoking Cessation Trial in Dually Diagnosed MenMelodie Isgro, Neal Doran, Jaimee L Heffner, et al.Journal of Clinical Psychopharmacology|February 28, 2019
Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES TrialA Eden Evins, Neal L Benowitz, Robert West, et al.Journal of Affective Disorders|June 14, 2019
Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trialJaimee L Heffner, A Eden Evins, Cristina Russ, et al.Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|August 18, 2011
Selegiline transdermal system (STS) as an aid for smoking cessationRoberta Kahn, Liza Gorgon, Karen Jones, et al.The American Journal of Psychiatry|December 11, 2024
Effects of Varenicline, Bupropion, Nicotine Patch, and Placebo on Treating Smoking Among Persons With Current or Past Major Depressive Disorder: Secondary Analysis of a Double-Blind, Randomized, Placebo-Controlled TrialGeorge Kypriotakis, Paul M Cinciripini, Charles E Green, et al.Addiction (Abingdon, England)|April 22, 2021
Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factorsEmma Beard, Sarah E Jackson, Robert M Anthenelli, et al.Pageof 7